Stay updated on Intratumoral SD-101 + Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral SD-101 + Pembrolizumab Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Release notes now display Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates the page has been updated to reflect the latest revision.
    Difference
    0.0%
    Check dated 2026-05-20T06:51:48.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The site shows an updated revision from v3.5.2 to v3.5.3, indicating an incremental platform release. This update does not modify the study details presented on the page.
    Difference
    0.0%
    Check dated 2026-04-28T14:48:39.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now shows a different site revision number (v3.5.2 instead of v3.5.0). No other content on the study record appears to be changed.
    Difference
    0.0%
    Check dated 2026-04-21T09:48:16.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added 'Squamous cell carcinoma of the head and neck' as a disease topic and introduced a Resources section with the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-03-30T16:27:36.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-23T13:27:13.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Layout and navigation appear adjusted between the two screenshots, while core study sections such as endpoints, eligibility criteria, and enrollment show no visible changes.
    Difference
    0.0%
    Check dated 2026-03-16T03:27:41.000Z thumbnail image

Stay in the know with updates to Intratumoral SD-101 + Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.